Barrett's esophagus: Diagnostic approaches and surveillance

Seminars in Thoracic and Cardiovascular Surgery

Volumn 17, Issue 4, 2005, Pages 301-312

  Schuchert, Matthew J ^a,b   McGrath, Kevin ^a   Buenaventura, Percival O ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Barrett's esophagus; Chromendoscopy; Screening; Surveillance

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER RISK; CHROMOENDOSCOPY; CHRONIC DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DYSPLASIA; HUMAN; LAPAROSCOPIC SURGERY; OPTICAL COHERENCE TOMOGRAPHY; RAMAN SPECTROMETRY; SCREENING;

EID: 31144469432     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2005.09.003     Document Type: Article

References (64)

1. S.E. Attwood C.D. Morris Who defines Barrett's esophagus: Endoscopist or pathologist? Eur J Gastroenterol Hepatol 13 2001 97-99
2. R.E. Rudolph T.L. Vaughan B.E. Storer et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus Ann Intern Med 132 2000 612-620
3. M. Eloubeidi D. Provenzale Does the patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy Am J Gastroenterol 94 1999 937-943
4. D.K. Rex O.W. Cummings M. Shaw et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn Gastroenterology 125 2003 1670-1677
5. C.J. Winters T.J. Spurling S.J. Chobanian et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease Gastroenterology 92 1987 118-124
6. A. Soni R.E. Sampliner A. Sonnenberg Screening for high-grade dysplasia in gastroesophageal reflux disease: Is it cost-effective? Am J Gastroenterol 95 2000 2086-2093
7. P. Sharma E.I. Sidorenko Are screening and surveillance for Barrett's esophagus really worthwhile? Gut 54 suppl 1 2005 i27-i32
8. R.E. Sampliner Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 97 8 2002 1888-1895
9. M. Connor P. Sharma Chromendoscopy and magnification endoscopy in Barrett's esophagus Gastrointest Endosc Clin N Am 13 2003 269-277
10. M.I. Canto S. Setrakian R.E. Petras et al. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus Gastrointest Endosc 44 1996 1-7
11. M.I. Canto S. Setrakian J. Willis et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus Gastrointest Endosc 51 2000 560-568
12. J. Wo M. Ray S. Mayfield-Stokes et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: A preliminary study Gastrointest Endosc 54 2001 294-301
13. U. Dave A.S. Shousha D. Westaby Methylene blue staining: Is it really useful in Barrett's esophagus? Gastrointest Endosc 53 2001 333-335
14. H.P. Breyer S.G. Silva De Barros I. Maguilnik et al. Does methylene blue detect intestinal metaplasia in Barrett's esophagus? Gastrointest Endosc 57 2003 505-509
15. M. Guelrud I. Herrera H. Essenfeld et al. Enhanced magnification endoscopy: A new technique to identify specialized intestinal metaplasia in Barrett's esophagus Gastrointest Endosc 53 2001 559-565
16. P. Sharma A.P. Weston M. Topalovski et al. Magnification chromendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus Gut 52 2003 24-27
17. P.D. Stevens C.J. Lightdale P.H. Green et al. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus Gastrointest Endosc 40 1994 747-749
18. T. Endo T. Awakawa H. Takahashi et al. Classification of Barrett's epithelium by magnifying endoscopy Gastrointest Endosc 55 2002 641-647
19. Y. Hamamoto T. Endo K. Nosho et al. Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett's esophagus J Gastroenterol 39 1 2004 14-20
20. M. Panjehpour B.F. Overholt T. Vo-Dinh et al. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus Gastroenterology 111 1996 93-101
21. I. Georgakoudi J.C. Jacobson J. Van Dam et al. Fluorescence, reflectance, and light-scattering endoscopy for evaluating dysplasia in patients with Barrett's esophagus Gastroenterology 120 2001 1620-1629
22. J. Haringsma G.N. Tytgat H. Yano et al. Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology Gastrointest Endosc 53 2001 642-650
23. X.D. Li S.A. Boppart J. Van Dam et al. Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett's esophagus Endoscopy 32 2000 921-930
24. J.M. Poneros S. Brand B.E. Bouma et al. Diagnosis of specialized intestinal metaplasia by optical coherence tomography Gastroenterology 120 2001 7-12
25. G.W. Falk Barrett's esophagus Gastroenterology 122 2002 1569-1591
26. G.W. Falk R. Chittajallu J.R. Goldblum et al. Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology Gastroenterology 112 1997 1787-1797
27. M. Skacel M. Fahmy T.L. Gramlich Fluorescence in situ hybridization (FISH) of endoscopic brush cytology from Barrett's esophagus detects genetic changes in high-grade dysplasia and adenocarcinoma not seen in patients without dysplasia Gastrointest Endosc 57 2003 AB92
28. R.S. Dacosta B.C. Wilson N.E. Marcon New optical technologies for the earlier endoscopic diagnosis of premalignant gastrointestinal lesions J Gastroenterol Hepatol 17 suppl 2002 S85-S104
29. R.E. Sampliner Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 97 1999 1888-1895
30. J. Van Sandick J. vanLanschot B. Kuiken et al. Impact of endoscopic biopsy surveillance of Barrett's esophagus on pathological stage and clinical outcome of Barrett's carcinoma Gut 43 1998 216-222
31. P. Sharma D. Reker G. Falk et al. Progression of Barrett's esophagus to high grade dysplasia and cancer - preliminary results of the Barrett's esophagus study trial Gastroenterology 120 2001 A-16
32. N.S. Buttar K.K. Want T.J. Sebo et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma Gastroenterology 120 2001 1630-1639
33. D.S. Levine R.C. Haggitt P.L. Blount et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus Gastroenterology 105 1993 40-50
34. A.J. Cameron H.J. Carpenter Barrett's esophagus, high-grade dysplasia, and early carcinoma: A pathological study Am J Gastroenterol 92 1997 586-591
35. B.J. Reid P. Blount Z. Feng et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high grade dysplasia Am J Gastroenterol 95 2000 3089-3096
36. D.A. Corley T.R. Levin L.A. Habel et al. Surveillance and survival in Barrett's adenocarcinomas: A population-based study Gastroenterology 122 2002 633-640
37. A. Van der Burgh J. Dees W.C. Hop et al. Esophageal cancer is an uncommon cause of death in patients with Barrett's esophagus Gut 39 1996 5-8
38. C.E. MacDonald A.C. Wicks R.J. Playford Final results from 10 year cohort of patients undergoing surveillance in Barrett's esophagus: observational study BMJ 321 2000 1252-1255
39. T.G. Schnell S.J. Sontag G. Chejfec et al. Long-term non-surgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 127 7 2001 1607-1619
40. T.W. Rice G.W. Falk E. Achkar et al. Surgical management of high-grade dysplasia in Barrett's esophagus Am J Gastroenterol 88 1993 1832-1836
41. C.A. Pellegrini D. Pohl High grade dysplasia in Barrett's esophagus: surveillance or operation? J Gastrointest Surg 4 2000 131-134
42. M.S. Dar J.R. Goldblum T.W. Rice et al. Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy? Gut 52 2003 486-489
43. N.S. Buttar K.K. Wang T.J. Sebo et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma Gastroenterology 120 2001 1607-1619
44. B.J. Reid D.S. Levine G. Longton et al. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low and high-risk patient subsets Am J Gastroenterol 95 2000 1669-1676
45. S.G. Swisher L. Deford K.W. Merriman et al. Effects of operative volume on morbidity, mortality and hospital use after esophagectomy for cancer J Thorac Cardiovasc Surg 119 2000 1126-1132
46. J.D. Luketich N.T. Nguyen P. Schauer Laparoscopic transhiatal esophagectomy for Barrett's esophagus with high-grade dysplasia J Soc Laparoendoscop Surg 2 1998 75-77
47. A.F. Pierre J.D. Luketich Technique and role of minimally invasive esophagectomy for premalignant and malignant diseases of the esophagus Surg Oncol Clin N Am 11 2002 337-350
48. N.T. Nguyen P. Schauer J.D. Luketich Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia Surgery 127 2000 284-290
49. H.C. Fernando J.D. Luketich P.O. Buenaventura et al. Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus Eur J Cardiothor Surg 22 2002 1-6
50. S.J. Spechler Barrett's esophagus N Engl J Med 346 11 2002 836-842
51. C.E. MacDonald A.C. Wicks R.J. Playford Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study BMJ 321 2000 1252-1255
52. T.A. Wright M.R. Gray A.I. Morris et al. Cost-effectiveness of detecting Barrett's cancer Gut 39 1996 574-579
53. J.M. Streitz Jr F.H. Ellis Jr. R.L. Tilden et al. Endoscopic surveillance of Barrett's esophagus: A cost-effectiveness comparison with mammographic surveillance for breast cancer Am J Gastroenterol 93 1998 911-915
54. A. Sonnenberg A. Soni R.E. Sampliner Medical decision analysis of endoscopic surveillance of Barrett's esophagus to prevent oesophageal adenocarcinoma Aliment Pharmacol Ther 16 2002 41-50
55. D. Provenzale C. Schmitt J.B. Wong Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk Am J Gastroenterol 94 1999 2043-2053
56. W. Polkowski J.J. van Lanschot F.J. Kate et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence Surg Oncol 4 1995 163-171
57. C. Tselepis I. Perry C. Dawson et al. Tumor necrosis factor alpha in Barrett's oesophagus: A potential novel mechanism of action Oncogene 21 2002 6071-6081
58. C.J. Buskens B.P. Van Rees A. Sivula et al. Prognostic significance of elevated cyclo-oxygenase 2 expression in patients with adenocarcinoma of the esophagus Gastroenterology 122 2002 1800-1807
59. C.P. Morales R.F. Souza S.J. Spechler Hallmarks of cancer progression in Barrett's esophagus Lancet 360 2002 1587-1589
60. K.K. Krishnadath B.J. Reid K.K. Wang Biomarkers in Barrett's esophagus Mayo Clin Proc 76 2001 438-446
61. S. Raja S.D. Finckelstein F.K. Baksh et al. Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus Ann Thorac Surg 72 2001 1130-1135
62. Z. Zhuang A.O. Vortmeyer E.J. Mark et al. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma Cancer Res 56 9 1996 1961-1964
63. K.K. Krishnadath B.J. Reid K.K. Wang Biomarkers in Barrett esophagus Mayo Clin Proc 76 4 2001 438-446
64. B.J. Reid L.J. Prevo P.C. Galipeau et al. Predictors of progression in Barrett's esophagus II: Baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression Am J Gastroenterol 96 2001 2839-2848